FIELD: biotechnology.
SUBSTANCE: described oligonucleotides, that increase expression of a gene of fibroblast growth factor 21 (FGF21), by interaction with the natural targeting antisense polynucleotides fibroblast growth factor 21 (FGF21). The present invention also relates to the use of the described oligonucleotides for the treatment of diseases and disorders associated with the expression of FGF21.
EFFECT: invention expands the arsenal of tools aimed for the treatment of diseases and disorders associated with the expression of FGF21.
26 cl, 2 dwg, 3 ex, 1 tbl
Authors
Dates
2017-02-14—Published
2011-04-08—Filed